At the intersection of neuroscience and human endurance, Sheba Medical Center in Israel has begun offering a new experimental use of Deep Transcranial Magnetic Stimulation — not to treat a single condition, but to address the tangled network of pain, cognition, and mood that defines chronic suffering. For patients who have exhausted conventional medicine without relief, this magnetic approach represents both a clinical innovation and a quiet philosophical shift: that pain is not a signal to be silenced in one place, but a pattern woven across the whole brain, requiring a whole-brain response.
Israeli Hospital Launches Experimental Deep TMS for Chronic Pain
Patient with complex regional pain syndrome and PTSD from kindergarten accident reports significant improvement in pain, cognitive function, and quality of life following treatment.
Chronic pain lives in a network, not a single place
Mark
Why does it matter that they're targeting two brain regions instead of one?
Mimi
Because chronic pain isn't a single problem. It's a network. You have the pain signal itself, but also the cognitive fog, the memory problems, the mood collapse that comes with it. Targeting just the motor cortex might quiet the pain but leave you still unable to concentrate. This approach tries to address the whole thing.
Luke
But we should be clear—this is still experimental. It's not a formal clinical trial. They're using protocols that work for depression and PTSD, but applying them to pain is new territory.
Mark
How long does someone have to commit to this?
Mimi
Twelve weeks minimum. Three sessions a week for the first month, then one session a week for another month or two. It's not a quick fix.
Luke
And we don't yet know how long the benefits last. They're hoping the maintenance phase preserves the effect, but that's still being figured out.
Mark
Who can actually get this treatment?
Mimi
People with widespread chronic pain who've tried everything else and it hasn't worked. You have to be evaluated individually. Not everyone is eligible.
Luke
The hospital is being appropriately cautious about that. They're not overselling it as a cure-all. But it does mean access is limited, at least for now.
Mark
What's the actual risk?
Mimi
Mild headaches mostly, which go away. There's a very small seizure risk, but Ungar says that's extremely rare.
Luke
The safety profile seems solid, especially since the technology is already approved for depression and PTSD. But again, using it for pain is newer, so long-term effects in this specific application aren't fully known yet.
Il Polso
- Patients with chronic pain conditions that have resisted every standard treatment are arriving at Sheba's pain clinic carrying years of accumulated loss — in function, in cognition, in the simple ability to live a normal day.
- The urgency lies in what chronic pain takes beyond the body: one patient, injured in a kindergarten accident, has lived with both complex regional pain syndrome and PTSD, conditions that compound each other in ways conventional medicine has struggled to untangle.
- Deep TMS disrupts this pattern by stimulating two brain regions simultaneously — the motor cortex and the prefrontal area — targeting both the pain signal and the cognitive and emotional damage that travels with it.
- A structured twelve-session intensive phase, managed in part by a trained nineteen-year-old national-service volunteer, is followed by weeks of maintenance sessions designed to hold whatever neurological ground has been gained.
- Early patient reports point toward real improvements in pain intensity, concentration, memory, and nervous system sensitivity — signs that the treatment may be reaching the full architecture of suffering, not just its surface.
At the intersection of neuroscience and human endurance, Sheba Medical Center in Israel has begun offering a new experimental use of Deep Transcranial Magnetic Stimulation — not to treat a single condition, but to address the tangled network of pain, cognition, and mood that defines chronic suffering. For patients who have exhausted conventional medicine without relief, this magnetic approach represents both a clinical innovation and a quiet philosophical shift: that pain is not a signal to be silenced in one place, but a pattern woven across the whole brain, requiring a whole-brain response. It is early, and the evidence is still forming, but for at least one patient, something has already begun to change.
Inside Sheba Medical Center's pain clinic, a woman who has spent years navigating the aftermath of a childhood accident — complex regional pain syndrome layered over PTSD — has begun to notice something unfamiliar: the pain is quieter, and her mind feels more like her own. The treatment responsible is Deep TMS, a noninvasive therapy using a magnetic helmet to stimulate brain tissue and, in theory, reshape how the brain processes suffering.
What makes Sheba's approach distinctive is its dual targeting. Rather than focusing on a single brain region, clinicians simultaneously stimulate the motor cortex, which regulates pain signals, and the prefrontal region, which governs mood and cognition. The logic is straightforward: chronic pain does not live in one place. It inhabits a network. A treatment that addresses multiple nodes in that network might not only reduce pain but restore some of what pain has quietly taken away.
Dr. Lior Ungar, head of functional neurosurgery at Sheba, describes the approach as promising for patients with what he calls invisible illnesses — conditions that devastate daily life without leaving visible evidence. The treatment protocol begins with three sessions per week for four weeks, each involving a precisely positioned helmet generating controlled magnetic pulses. A maintenance phase follows, extending one to two months to preserve the gains made.
Sheba is not conducting a formal clinical trial. Instead, it is offering Deep TMS as an experimental treatment under existing medical standards, drawing on stimulation protocols already approved in Israel for depression and PTSD. Patients complete standardized questionnaires throughout to track changes in pain and function. Side effects are generally mild — most commonly a brief headache early in the series — with a rare risk of seizure.
For the woman at the center of this story, the improvements have extended beyond pain intensity to concentration, memory, and how her nervous system responds to the world around her. These are not small things. They are, as Ungar suggests, the difference between enduring a life and actually inhabiting one.
At Sheba Medical Center's pain clinic, a woman who spent years managing the aftermath of a kindergarten accident—complex regional pain syndrome, post-traumatic stress disorder, the accumulated weight of both—has begun to notice something shift. The pain is quieter. Her mind feels sharper. She credits a treatment she started just weeks ago: deep transcranial magnetic stimulation, or Deep TMS, a noninvasive therapy that uses a magnetic helmet to reach into the brain and, in theory, rewire how it processes suffering.
Deep TMS is not new. The technology has been approved in Israel's public health system for treatment-resistant depression and is available through the Defense Ministry for PTSD. What is new is how Sheba is deploying it. Rather than targeting a single brain region, the hospital's approach stimulates two key areas simultaneously: the motor cortex, which regulates pain signals, and the prefrontal region, which governs cognition and mood. The idea is elegantly simple—chronic pain does not live in one place in the brain. It lives in a network. A treatment that addresses multiple nodes in that network might do more than reduce pain; it might restore some of what pain has taken.
Dr. Lior Ungar, deputy director of Sheba's neurosurgery department and head of functional neurosurgery, describes the approach as innovative and, at this stage, promising. The brain works through connectivity between regions, he explains. A treatment that targets several sites at once may produce a broader response than one aimed at a single target. For patients with what he calls invisible illnesses—conditions that devastate function and quality of life but leave no visible mark—this matters. The woman who began treatment reported improvements not just in pain intensity but in concentration, memory, and how her nervous system responds to stimuli. These are the things that make a life livable.
The treatment itself follows a structured arc. Patients begin with an intensive phase: three sessions a week for four weeks. A magnetic helmet, precisely positioned, generates controlled pulses that induce electrical activity in deeper brain tissue. The sessions are managed by Yakira Ne'eman, a nineteen-year-old national-service volunteer who has trained with the medical-device company BrainsWay and now calibrates equipment, positions the helmet, and maintains contact with patients throughout the series. After the intensive phase comes maintenance: one session a week for one to two months, an attempt to preserve whatever gains have been made.
Not every patient qualifies. Sheba is offering the treatment primarily to those with widespread chronic pain who have exhausted conventional options without adequate relief. A medical evaluation at the pain clinic determines suitability, accounting for each person's condition and the standard contraindications for magnetic stimulation. The hospital is not running a formal clinical trial. Instead, it is offering Deep TMS as an experimental treatment under existing medical standards, combining stimulation protocols already approved for PTSD and depression. Patients complete standardized questionnaires before, during, and after treatment to provide systematic measurement of changes in pain and daily function.
The side effects are modest. The most common is a mild headache at the beginning of the treatment series, usually resolving quickly. There is a rare risk of seizure. Overall, Ungar says, the treatment is considered safe. The initial data in pain treatment are encouraging, though the field is still early. Sheba's hope is not only to reduce pain but to achieve lasting improvement in cognitive functions and mood—to address, in other words, not just the symptom but the whole person living with it. For the woman who began treatment after her accident, that distinction may be the difference between surviving and actually living again.
Citazioni salienti
With chronic pain, we are not dealing with one area of the brain, but with an entire network of regions involved both in the pain itself and in the accompanying symptoms.— Dr. Lior Ungar, deputy director of Sheba's neurosurgery department
I feel the treatment has helped improve my cognitive abilities and executive functions. Since starting the treatment, the pain and my nervous system's sensitivity to stimuli have also decreased.— Patient undergoing Deep TMS treatment
Vuoi la storia completa?
Leggi l'originale su Ynetnews ↗
Health & Medicine